Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -13,31k | 218,17k | Automatic Disposition | 16,38 - 16,39 | 232,46k | -5,42% |
| 2026-05-20 | Mr. Rick E. WinninghamCEO & Director | -20,04k | 331,63k | Sale to Issuer | 16,55 | 1,75M | -1,13% |
| 2026-05-20 | Mr. Aziz SawafSenior VP & CFO | -8,67k | 143,49k | Sale to Issuer | 16,55 | 344,95k | -2,45% |
| 2026-05-20 | Dr. Aine MillerSenior VP of Development & Head of Ireland Office | -6,83k | 112,99k | Sale to Issuer | 16,55 | 177,33k | -3,71% |
| 2026-05-20 | Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary | -8,83k | 146,12k | Sale to Issuer | 16,55 | 363,12k | -2,37% |
| 2026-05-20 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -5,68k | 93,97k | Sale to Issuer | 16,55 | 245,77k | -2,26% |
| 2026-03-16 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -31,07k | 433,64k | Automatic Disposition | 13,92 - 14,00 | 232,70k | -11,78% |
| 2026-02-20 | Mr. Rick E. WinninghamCEO & Director | -74,98k | 1,47M | Sale to Issuer | 19,66 | 1,69M | -4,24% |
| 2026-02-20 | Mr. Aziz SawafSenior VP & CFO | -20,67k | 406,41k | Sale to Issuer | 19,66 | 316,12k | -6,14% |
| 2026-02-20 | Dr. Aine MillerSenior VP of Development & Head of Ireland Office | -16,85k | 331,29k | Sale to Issuer | 19,66 | 184,16k | -8,38% |
| 2026-02-20 | Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary | -20,83k | 409,58k | Sale to Issuer | 19,66 | 334,45k | -5,86% |
| 2026-02-20 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -13,93k | 273,84k | Sale to Issuer | 19,66 | 263,77k | -5,02% |
| 2025-12-03 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -31,07k | 582,50k | Automatic Disposition | 18,75 | 277,70k | -10,06% |
| 2025-11-26 | Mr. Eran BroshyInsider | -29,50k | 590,02k | Automatic Disposition | 20,00 | 34,05k | -46,42% |
| 2025-11-20 | Mr. Aziz SawafSenior VP & CFO | -18,63k | 333,42k | Sale to Issuer | 17,90 | 336,80k | -5,24% |
| 2025-11-20 | Dr. Aine MillerSenior VP of Development & Head of Ireland Office | -6,99k | 125,10k | Sale to Issuer | 17,90 | 201,01k | -3,36% |
| 2025-11-20 | Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary | -19,02k | 340,53k | Sale to Issuer | 17,90 | 355,28k | -5,08% |
| 2025-11-20 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -9,06k | 162,17k | Sale to Issuer | 17,90 | 308,76k | -2,85% |
| 2025-11-20 | Mr. Rick E. WinninghamCEO & Director | -56,82k | 1,02M | Sale to Issuer | 17,90 | 1,77M | -3,12% |
| 2025-11-19 | Mr. Rick E. WinninghamCEO & Director | -9,90k | 0,00 | Other Disposition | - | 1,77M | -0,56% |
| 2025-11-11 | Mr. Eran BroshyInsider | -45,00k | 809,25k | Automatic Disposition | 17,00 - 18,50 | 49,56k | -47,59% |
| 2025-08-20 | Mr. Rick E. WinninghamCEO & Director | -15,39k | 206,13k | Sale to Issuer | 13,39 | 1,82M | -0,84% |
| 2025-08-20 | Mr. Aziz SawafSenior VP & CFO | -9,37k | 125,44k | Sale to Issuer | 13,39 | 355,42k | -2,57% |
| 2025-08-20 | Dr. Aine MillerSenior VP of Development & Head of Ireland Office | -6,99k | 93,58k | Sale to Issuer | 13,39 | 208,00k | -3,25% |
| 2025-08-20 | Mr. Brett A. GrimaudSenior VP, General Counsel & Secretary | -9,76k | 130,71k | Sale to Issuer | 13,39 | 374,31k | -2,54% |
| 2025-08-20 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -9,10k | 121,80k | Sale to Issuer | 13,39 | 317,82k | -2,78% |
| 2025-07-14 | Ms. Rhonda F. FarnumChief Business Officer and Senior VP of Commercial & Medical Affairs | -10,00k | 113,87k | Automatic Disposition | 11,39 | 326,92k | -2,97% |
| 2025-06-23 | Mr. Rick E. WinninghamCEO & Director | -20,00k | 0,00 | Other Disposition | - | 1,84M | -1,08% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
